Interventions to Address Medical Conditions and Health-Risk Behaviors among Persons with Serious Mental Illness

A Comprehensive Review

Emma Beth McGinty, Julia Baller, Susan T. Azrin, Denise Juliano-Bult, Gail L Daumit

Research output: Contribution to journalArticle

Abstract

People with serious mental illness (SMI) have mortality rates 2 to 3 times higher than the overall US population, largely due to cardiovascular disease. The prevalence of cardiovascular risk factors such as obesity and diabetes mellitus and other conditions, such as HIV/AIDS, is heightened in this group. Based on the recommendations of a National Institute of Mental Health stakeholder meeting, we conducted a comprehensive review examining the strength of the evidence surrounding interventions to address major medical conditions and health-risk behaviors among persons with SMI. Peer-reviewed studies were identified using 4 major research databases. Randomized controlled trials and observational studies testing interventions to address medical conditions and risk behaviors among persons with schizophrenia and bipolar disorder between January 2000 and June 2014 were included. Information was abstracted from each study by 2 trained reviewers, who also rated study quality using a standard tool. Following individual study review, the quality of the evidence (high, medium, low) and the effectiveness of various interventions were synthesized. 108 studies were included. The majority of studies examined interventions to address overweight/obesity (n = 80). The strength of the evidence was high for 4 interventions: metformin and behavioral interventions had beneficial effects on weight loss; and bupropion and varenicline reduced tobacco smoking. The strength of the evidence was low for most other interventions reviewed. Future studies should test long-term interventions to cardiovascular risk factors and health-risk behaviors. In addition, future research should study implementation strategies to effectively translate efficacious interventions into real-world settings.

Original languageEnglish (US)
Pages (from-to)96-124
Number of pages29
JournalSchizophrenia Bulletin
Volume42
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Risk-Taking
Health
Obesity
National Institute of Mental Health (U.S.)
Bupropion
Metformin
Bipolar Disorder
Observational Studies
Weight Loss
Schizophrenia
Diabetes Mellitus
Acquired Immunodeficiency Syndrome
Cardiovascular Diseases
Randomized Controlled Trials
Smoking
HIV
Databases
Mortality
Research
Population

Keywords

  • intervention
  • medical
  • obesity
  • schizophrenia
  • somatic
  • tobacco

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Interventions to Address Medical Conditions and Health-Risk Behaviors among Persons with Serious Mental Illness : A Comprehensive Review. / McGinty, Emma Beth; Baller, Julia; Azrin, Susan T.; Juliano-Bult, Denise; Daumit, Gail L.

In: Schizophrenia Bulletin, Vol. 42, No. 1, 01.01.2016, p. 96-124.

Research output: Contribution to journalArticle

@article{68d22636d60044e38ca544ffe87a3b6d,
title = "Interventions to Address Medical Conditions and Health-Risk Behaviors among Persons with Serious Mental Illness: A Comprehensive Review",
abstract = "People with serious mental illness (SMI) have mortality rates 2 to 3 times higher than the overall US population, largely due to cardiovascular disease. The prevalence of cardiovascular risk factors such as obesity and diabetes mellitus and other conditions, such as HIV/AIDS, is heightened in this group. Based on the recommendations of a National Institute of Mental Health stakeholder meeting, we conducted a comprehensive review examining the strength of the evidence surrounding interventions to address major medical conditions and health-risk behaviors among persons with SMI. Peer-reviewed studies were identified using 4 major research databases. Randomized controlled trials and observational studies testing interventions to address medical conditions and risk behaviors among persons with schizophrenia and bipolar disorder between January 2000 and June 2014 were included. Information was abstracted from each study by 2 trained reviewers, who also rated study quality using a standard tool. Following individual study review, the quality of the evidence (high, medium, low) and the effectiveness of various interventions were synthesized. 108 studies were included. The majority of studies examined interventions to address overweight/obesity (n = 80). The strength of the evidence was high for 4 interventions: metformin and behavioral interventions had beneficial effects on weight loss; and bupropion and varenicline reduced tobacco smoking. The strength of the evidence was low for most other interventions reviewed. Future studies should test long-term interventions to cardiovascular risk factors and health-risk behaviors. In addition, future research should study implementation strategies to effectively translate efficacious interventions into real-world settings.",
keywords = "intervention, medical, obesity, schizophrenia, somatic, tobacco",
author = "McGinty, {Emma Beth} and Julia Baller and Azrin, {Susan T.} and Denise Juliano-Bult and Daumit, {Gail L}",
year = "2016",
month = "1",
day = "1",
doi = "10.1093/schbul/sbv101",
language = "English (US)",
volume = "42",
pages = "96--124",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Interventions to Address Medical Conditions and Health-Risk Behaviors among Persons with Serious Mental Illness

T2 - A Comprehensive Review

AU - McGinty, Emma Beth

AU - Baller, Julia

AU - Azrin, Susan T.

AU - Juliano-Bult, Denise

AU - Daumit, Gail L

PY - 2016/1/1

Y1 - 2016/1/1

N2 - People with serious mental illness (SMI) have mortality rates 2 to 3 times higher than the overall US population, largely due to cardiovascular disease. The prevalence of cardiovascular risk factors such as obesity and diabetes mellitus and other conditions, such as HIV/AIDS, is heightened in this group. Based on the recommendations of a National Institute of Mental Health stakeholder meeting, we conducted a comprehensive review examining the strength of the evidence surrounding interventions to address major medical conditions and health-risk behaviors among persons with SMI. Peer-reviewed studies were identified using 4 major research databases. Randomized controlled trials and observational studies testing interventions to address medical conditions and risk behaviors among persons with schizophrenia and bipolar disorder between January 2000 and June 2014 were included. Information was abstracted from each study by 2 trained reviewers, who also rated study quality using a standard tool. Following individual study review, the quality of the evidence (high, medium, low) and the effectiveness of various interventions were synthesized. 108 studies were included. The majority of studies examined interventions to address overweight/obesity (n = 80). The strength of the evidence was high for 4 interventions: metformin and behavioral interventions had beneficial effects on weight loss; and bupropion and varenicline reduced tobacco smoking. The strength of the evidence was low for most other interventions reviewed. Future studies should test long-term interventions to cardiovascular risk factors and health-risk behaviors. In addition, future research should study implementation strategies to effectively translate efficacious interventions into real-world settings.

AB - People with serious mental illness (SMI) have mortality rates 2 to 3 times higher than the overall US population, largely due to cardiovascular disease. The prevalence of cardiovascular risk factors such as obesity and diabetes mellitus and other conditions, such as HIV/AIDS, is heightened in this group. Based on the recommendations of a National Institute of Mental Health stakeholder meeting, we conducted a comprehensive review examining the strength of the evidence surrounding interventions to address major medical conditions and health-risk behaviors among persons with SMI. Peer-reviewed studies were identified using 4 major research databases. Randomized controlled trials and observational studies testing interventions to address medical conditions and risk behaviors among persons with schizophrenia and bipolar disorder between January 2000 and June 2014 were included. Information was abstracted from each study by 2 trained reviewers, who also rated study quality using a standard tool. Following individual study review, the quality of the evidence (high, medium, low) and the effectiveness of various interventions were synthesized. 108 studies were included. The majority of studies examined interventions to address overweight/obesity (n = 80). The strength of the evidence was high for 4 interventions: metformin and behavioral interventions had beneficial effects on weight loss; and bupropion and varenicline reduced tobacco smoking. The strength of the evidence was low for most other interventions reviewed. Future studies should test long-term interventions to cardiovascular risk factors and health-risk behaviors. In addition, future research should study implementation strategies to effectively translate efficacious interventions into real-world settings.

KW - intervention

KW - medical

KW - obesity

KW - schizophrenia

KW - somatic

KW - tobacco

UR - http://www.scopus.com/inward/record.url?scp=84954358010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954358010&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbv101

DO - 10.1093/schbul/sbv101

M3 - Article

VL - 42

SP - 96

EP - 124

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 1

ER -